New Computer-Aided Diagnosis of Dementia Using Positron Emission Tomography: Brain Regional Sensitivity-Mapping Method
暂无分享,去创建一个
Hiroyuki Okada | Sadahiko Nishizawa | Yasuomi Ouchi | Etsuji Yoshikawa | Satoshi Minoshima | S. Minoshima | S. Nishizawa | E. Yoshikawa | Y. Ouchi | H. Okada | A. Kakimoto | Y. Kamekawa | S. Ito | Shigeru Ito | Akihiro Kakimoto | Yuichi Kamekawa
[1] M. Wortmann,et al. World Alzheimer Report 2009 - Executive Summary , 2009 .
[2] Karl J. Friston,et al. Statistical parametric mapping , 2013 .
[3] L. Mosconi,et al. Brain glucose metabolism in the early and specific diagnosis of Alzheimer’s disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[4] Karl Herholz,et al. On the multivariate nature of brain metabolic impairment in Alzheimer's disease , 2009, Neurobiology of Aging.
[5] D. Schenk. Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning , 2002, Nature Reviews Neuroscience.
[6] T. Kosugi,et al. A new high resolution PET scanner dedicated to brain research , 2001 .
[7] L. Garey. Brodmann's localisation in the cerebral cortex , 1999 .
[8] A. Drzezga,et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[9] D. Perani,et al. MCI conversion to dementia and the APOE genotype , 2004, Neurology.
[10] Yaakov Stern,et al. Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance , 2004, NeuroImage.
[11] H. Rusinek,et al. Regional analysis of FDG and PIB-PET images in normal aging, mild cognitive impairment, and Alzheimer’s disease , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[12] D. Schenk. Amyloid-beta immunotherapy for Alzheimer's disease: the end of the beginning. , 2002, Nature reviews. Neuroscience.
[13] M. Citron,et al. Strategies for disease modification in Alzheimer's disease , 2004, Nature Reviews Neuroscience.
[14] Sanjiv S Gambhir,et al. Evaluating early dementia with and without assessment of regional cerebral metabolism by PET: a comparison of predicted costs and benefits. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] A. Drzezga,et al. Decline of cerebral glucose metabolism in frontotemporal dementia: a longitudinal 18F-FDG-PET-study , 2007, Neurobiology of Aging.
[16] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[17] A. Burns. Clinical diagnosis of Alzheimer's disease , 1991 .
[18] N. Perkins,et al. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. , 2006, American journal of epidemiology.
[19] A. Convit,et al. Reduced hippocampal metabolism in MCI and AD , 2005, Neurology.
[20] George Mendelson,et al. Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) , 2009 .
[21] Martin W. Bunder,et al. The inconsistency of , 1976, Journal of Symbolic Logic.
[22] Hiroshi Fukuda,et al. Predicting human performance by channelized Hotelling observer in discriminating between Alzheimer’s dementia and controls using statistically processed brain perfusion SPECT , 2006, Annals of nuclear medicine.
[23] A. Akobeng,et al. Understanding diagnostic tests 3: receiver operating characteristic curves , 2007, Acta paediatrica.
[24] Robert A. Dean,et al. Effects of a γ-secretase inhibitor in a randomized study of patients with Alzheimer disease , 2006, Neurology.
[25] R. Koeppe,et al. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[26] Alberto Pupi,et al. Visual rating of medial temporal lobe metabolism in mild cognitive impairment and Alzheimer’s disease using FDG-PET , 2006, European Journal of Nuclear Medicine and Molecular Imaging.
[27] J. Hodges,et al. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.
[28] J. Morris,et al. Current concepts in mild cognitive impairment. , 2001, Archives of neurology.
[29] P. Tariot,et al. Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease. , 2006, Neurology.
[30] M. Bobinski,et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-d-glucose/positron-emission tomography (FDG/PET) , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[31] B. Reiser,et al. Estimation of the Youden Index and its Associated Cutoff Point , 2005, Biometrical journal. Biometrische Zeitschrift.
[32] J. S. Lee,et al. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients. , 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[33] G Mariani,et al. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[34] D. Perani,et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. , 2005, Archives of neurology.
[35] K. Ritchie. Mild cognitive impairment: an epidemiological perspective , 2004, Dialogues in clinical neuroscience.
[36] Satoshi Minoshima,et al. Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation , 2001, Annals of neurology.
[37] Guido Rodriguez,et al. Principal component analysis of FDG PET in amnestic MCI , 2008, European Journal of Nuclear Medicine and Molecular Imaging.
[38] R. Koeppe,et al. Anatomic standardization: linear scaling and nonlinear warping of functional brain images. , 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[39] A. Convit,et al. Hippocampal formation glucose metabolism and volume losses in MCI and AD , 2001, Neurobiology of Aging.
[40] M. Torrens. Co-Planar Stereotaxic Atlas of the Human Brain—3-Dimensional Proportional System: An Approach to Cerebral Imaging, J. Talairach, P. Tournoux. Georg Thieme Verlag, New York (1988), 122 pp., 130 figs. DM 268 , 1990 .
[41] J. Cummings,et al. Cholinesterase inhibitors: A new class of psychotropic compounds. , 2000, The American journal of psychiatry.
[42] L. Kurlowicz,et al. The Mini Mental State Examination (MMSE). , 1999, Director.
[43] K. Ishii,et al. Cerebral glucose metabolism in patients with frontotemporal dementia. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[44] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[45] R. Albin,et al. Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease , 1996, Neurology.